Avion Health vs GE HealthCare
Side-by-side comparison of AI visibility scores, market position, and capabilities
US YC W20 medical drone delivery of pharma/blood/diagnostics to remote clinics; $4.73M seed 2024-2025 with eVTOL drones and autonomous routing competing with Zipline for rural healthcare supply chain access.
About
Avion Health is a United States-based drone-based medical supply delivery platform — backed by Y Combinator (W20) with $4.73 million in seed funding in 2024-2025 — providing healthcare facilities and communities with autonomous eVTOL (electric vertical take-off and landing) drone delivery of vital medical supplies including pharmaceuticals, blood products, and diagnostic samples, bridging the accessibility gap between remote clinics and urban healthcare infrastructure. Operating pilot programs across the United States and internationally, Avion's drones feature GPS tracking, autonomous route correction, and real-time diagnostics — delivering to hard-to-reach areas with significant time savings compared to ground transportation and enabling same-hour medical supply access in geographies where traditional logistics are too slow for clinical urgency. Founded in 2019.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
About
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.